The role of DRP1 in ropivacaine-induced mitochondrial dysfunction and neurotoxicity

References

• Bodenham AR, Howell SJ. General anaesthesia vs local anaesthesia: an ongoing story. Br J Anaesth. 2009;103:785–789.
   PubMed Web of Science ®Google Scholar
• Becker DE, Reed KL. Local anesthetics: review of pharmacological considerations. Anesth Prog. 2012;59:90–102.
   PubMedGoogle Scholar
• Shipton EA. New formulations of local anaesthetics-part I. Anesthesiol Res Pract. 2012;2012:546409.
   PubMedGoogle Scholar
• Lirk P, Picardi S, Hollmann MW. Local anaesthetics: 10 Essentials. Eur J Anaesthesiol. 2014;31:575–585.
   PubMed Web of Science ®Google Scholar
• Verlinde M, Hollmann MW, Stevens MF, et al. Local anesthetic-induced neurotoxicity. Int J Mol Sci. 2016;17:339.
   PubMed Web of Science ®Google Scholar
• Sekimoto K, Tobe M, Saito S. Local anesthetic toxicity: acute and chronic management. Acute Med Surg. 2017;4:152–160.
   PubMed Web of Science ®Google Scholar
• Werdehausen R, Fazeli S, Braun S, et al. Apoptosis induction by different local anaesthetics in a neuroblastoma cell line. Br J Anaesth. 2009;103:711–718.
   PubMed Web of Science ®Google Scholar
• Cereda CM, Tofoli GR, Maturana LG, et al. Local neurotoxicity and myotoxicity evaluation of cyclodextrin complexes of bupivacaine and ropivacaine. Local neurotoxicity and myotoxicity evaluation of cyclodextrin complexes of bupivacaine and ropivacaine. Anesth Analg. 2012;115:1234–1241.
   PubMed Web of Science ®Google Scholar
• Zhang K, Yang S, Luo C. TNF-alpha and TNF-R1 regulate bupivacaine-induced apoptosis in spinal cord dorsal root ganglion neuron. Eur J Pharmacol. 2018;833:63–68.
   PubMed Web of Science ®Google Scholar
• Zheng J, Chen J, Wu G, et al. Inhibiting EZH2 rescued bupivacaine-induced neuronal apoptosis in spinal cord dorsal root ganglia in mice. J Anesth. 2018;32:524–530.
   PubMed Web of Science ®Google Scholar
• Casati A, Putzu M. levobupivacaine and ropivacaine: are they clinically different? Best Pract Res Clin Anaesthesiol. 2005;19:247–268.
   PubMedGoogle Scholar
• Piegeler T, Votta-Velis EG, Bakhshi FR, et al. Endothelial barrier protection by local anesthetics: ropivacaine and lidocaine block tumor necrosis factor-α-induced endothelial cell Src activation. Anesthesiology 2014;120:1414–1428.
   PubMed Web of Science ®Google Scholar
• Siekevitz P. Powerhouse of the Cell. Sci Am. 1957;197:131–144.
   Web of Science ®Google Scholar
• Picard M, Wallace DC, Burelle Y. The rise of mitochondria in medicine. Mitochondrion 2016;30:105–116.
   PubMed Web of Science ®Google Scholar
• Tandler B, Hoppel CL, Mears JA. Morphological pathways of mitochondrial division. Antioxidants (Basel). 2018;7:30.
   PubMedGoogle Scholar
• Gong Q, Wen X, Li H, et al. Up-regulation of Cav3.1 expression in SH-SY5Y cells induced by lidocaine hydrochloride. Artif Cells Nanomed Biotechnol. 2018;12:1–8.
   Google Scholar
• Askari S, Salehi R, Zarghami N, et al. The anticancer effects of biodegradable nanomagnetic dual natural components on the leptin gene expression in lung cancer. Artif Cells Nanomed Biotechnol. 2016;44:1753–1763.
   PubMed Web of Science ®Google Scholar
• Sheng B, Wang X, Su B, et al. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer’s disease. J Neurochem. 2012;120:419–429.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu X, Qiu Y, et al. Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells. J Hematol Oncol 2018;11:11.
   PubMed Web of Science ®Google Scholar
• Xie X, Xu X, Sun C, et al. Protective effects of cilostazol on ethanol-induced damage in primary cultured hepatocytes. Cell Stress Chaperones. 2018;23:203–211.
   PubMed Web of Science ®Google Scholar
• Manczak M, Kandimalla R, Yin X, et al. Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity. Hum Mol Genet. 2019;28:177–199.
   PubMed Web of Science ®Google Scholar
• Lutz AK, Exner N, Fett ME, et al. Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J Biol Chem. 2009;284:22938–22951.
   PubMed Web of Science ®Google Scholar
• da Silva EP, Jr, Nachbar RT, Levada-Pires AC, et al. Omega-3 fatty acids differentially modulate enzymatic anti-oxidant systems in skeletal muscle cells. Cell Stress Chaper. 2016;21:87–95.
   PubMed Web of Science ®Google Scholar
• Ben Salem I, Prola A, Boussabbeh M, et al. Crocin and Quercetin protect HCT116 and HEK293 cells from Zearalenone-induced apoptosis by reducing endoplasmic reticulum stress. Cell Stress Chaper. 2015;20:927–938.
   PubMed Web of Science ®Google Scholar
• Park CJ, Park SA, Yoon TG, et al. Bupivacaine induces apoptosis via ROS in the Schwann cell line. J Dent Res. 2005;84:852–857.
   PubMed Web of Science ®Google Scholar
• Kandimalla R, Reddy PH. Multiple faces of dynamin-related protein 1 and its role in Alzheimer’s disease pathogenesis. Biochim Biophys Acta. 2016;1862:814–828.
   PubMed Web of Science ®Google Scholar
• Kandimalla R, Manczak M, Fry D, et al. Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer’s disease. Hum Mol Genet. 2016;25:4881–4897.
   PubMed Web of Science ®Google Scholar
• Manczak M, Kandimalla R, Fry D, et al. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer’s disease. Hum Mol Genet 2016;25:5148–5166.
   PubMed Web of Science ®Google Scholar
• Graf BM, Abraham I, Eberbach N, et al. Differences in cardiotoxicity of bupivacaine and ropivacaine are the result of physicochemical and stereoselective properties. Anesthesiology 2002;96:1427–1434.
   PubMed Web of Science ®Google Scholar
• de Castro IP, Martins LM, Tufi R. Mitochondrial quality control and neurological disease: an emerging connection. Expert Rev Mol Med. 2010;12:e12.
   PubMed Web of Science ®Google Scholar
• Selander D, Sjovall J, Waldenlind L. Accidental i.v. injections of ropivacaine: clinical experiences of six cases. Reg Anesth. 1997;22:70.
   Google Scholar
• Ruetsch YA, Fattinger KE, Borgeat A. Ropivacaine-induced convulsions and severe cardiac dysrhythmia after sciatic block. Anesthesiology 1999;90:1784–1786.
   PubMed Web of Science ®Google Scholar
• Klein SM, Benveniste H. Anxiety, vocalization, and agitation following peripheral nerve block with ropivacaine. Reg Anesth Pain Med. 1999;24:175–178.
   PubMed Web of Science ®Google Scholar
• Ganapathy S, Sandhu HB, Stockall CA, et al. Transient neurologic symptom (TNS) following intrathecal ropivacaine. Anesthesiology 2000;93:1537–1539.
   PubMed Web of Science ®Google Scholar
• Muller M, Litz RJ, Huler M. Grand mal convulsion and plasma concentrations after intravascular injection of ropivacaine for axillary brachial plexus blockade. Br J Anaesth. 2001;87:784–787.
   PubMed Web of Science ®Google Scholar
• Al-Nasser B. Toxic effects of epidural analgesia with ropivacaine 0.2% in a diabetic patient. J Clin Anesth. 2004;16:220–223.
   PubMed Web of Science ®Google Scholar
• Dhir S, Ganapathy S, Lindsay P, et al. Case report: ropivacaine neurotoxicity at clinical doses in interscalene brachial plexus block. Can J Anesth/J Can Anesth. 2007;54:912–916.
   PubMed Web of Science ®Google Scholar
• Rodolà F, Anastasi F, Vergari A. Ropivacaine induced acute neurotoxicity after epidural injection. Eur Rev Med Pharmacol Sci. 2007;11:133–135.
   PubMed Web of Science ®Google Scholar
• Bagdure DN, Reiter PD, Bhoite GR, et al. Persistent hiccups associated with epidural ropivacaine in a newborn. Ann Pharmacother. 2011;45:e35.
   PubMedGoogle Scholar
• Feldman HS, Arthur GR, Covino BG. Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog. Anesth Analg. 1989;69:794–801.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Qulian G, Yuan Z, et al. Repeated intrathecal administration of ropivacaine causes neurotoxicity in rats. Anaesth Intensive Care. 2009;37:929–936.
   PubMed Web of Science ®Google Scholar
• Whitlock EL, Brenner MJ, Fox IK, et al. Ropivacaine-induced peripheral nerve injection injury in the rodent model. Anesth Analg. 2010;111:214–220.
   PubMed Web of Science ®Google Scholar
• Li L, Zhang T, Diao Y, et al. Injection of ropivacaine into the subarachnoid changes the ultrastructure and proteome of the rat spinal cord. Xenobiotica. 2013;43:908–914.
   PubMed Web of Science ®Google Scholar
• Xing Y, Zhang N, Zhang W, et al. Bupivacaine indirectly potentiates glutamate-induced intracellular calcium signaling in rat hippocampal neurons by impairing mitochondrial function in cocultured astrocytes. Anesthesiology 2018;128:539–554.
   PubMed Web of Science ®Google Scholar
• Sztark F, Malgat M, Dabadie P, et al. Comparison of the effects of bupivacaine and ropivacaine on heart cell mitochondrial bioenergetics. Anesthesiology 1998;88:1340–1349.
   PubMed Web of Science ®Google Scholar
• Grishko V, Xu M, Wilson G, et al. Apoptosis and mitochondrial dysfunction in human chondrocytes following exposure to lidocaine, bupivacaine, and ropivacaine. J Bone Joint Surg Am. 2010;92:609–618.
   PubMed Web of Science ®Google Scholar
• Cai XY, Xia Y, Yang SH, et al. Ropivacaine- and bupivacaine-induced death of rabbit annulus fibrosus cells in vitro: involvement of the mitochondrial apoptotic pathway. Osteoarthritis Cartilage. 2015;23:1763–1775.
   PubMed Web of Science ®Google Scholar